JD
Insider
Jason B. Daly
SVP, Chief Legal OfficerJason B. Daly (SVP, Chief Legal Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Amneal Pharmaceuticals, Inc. (AMRX). The largest single filing was $3.8M of AMRX (216,613 sh across 2 lots, as filed), executed Aug 11.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$3.8M
shares × price, as filed
Last traded
Aug 12
Filed Aug 13
Median ADV $37.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $5.3M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
AMRX
Amneal Pharmaceuticals, Inc.
AMRX · 0 buys · 5 sells
5 filings
Recent filings
AMRXSALE
Amneal Pharmaceuticals, Inc.
View filing →
$3.8M216,613 sh across 2 lots
Exec Aug 11
Filed Aug 13 · 4:21 PM ET AMRXSALE Amneal Pharmaceuticals, Inc. View filing → $199K
22,000 sh × $9.05
Exec Aug 12 2025
Filed Aug 13 2025 · 5:30 PM ET AMRXSALE Amneal Pharmaceuticals, Inc. View filing → $792K
90,000 sh across 2 lots
Exec Mar 5 2025
Filed Mar 7 2025 · 5:30 PM ET AMRXSALE Amneal Pharmaceuticals, Inc. View filing → $115K
13,665 sh × $8.40
Exec Nov 21 2024
Filed Nov 22 2024 · 5:30 PM ET AMRXSALE Amneal Pharmaceuticals, Inc. View filing → $376K
43,657 sh × $8.61
Exec Nov 15 2024
Filed Nov 19 2024 · 5:30 PM ET